Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM) Dividend History

Quantum Biopharma Ltd. is a biotechnology company focused on developing and commercializing innovative therapies in the biopharmaceutical sector. The company aims to leverage advanced scientific research to create targeted treatments, particularly in areas such as neurodegenerative diseases and other unmet medical needs. Its Class B subordinate voting shares (QNTM) represent equity ownership and voting rights within the company, offering investors opportunities to participate in its growth and development efforts.

Website: https://www.fsdpharma.com

Dividend History

Quantum Biopharma Ltd. Class B Subordinate Voting Shares currently does not pay dividends

Company News

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Quantum BioPharma plans to issue a special dividend of Contingent Value Rights (CVRs) to shareholders, which will entitle them to a portion of any net proceeds recovered from the company's legal action against several banks for alleged stock price manipulation.

GlobeNewswire Inc.
Quantum BioPharma Shares Are Up Over 80%: What's Going On?

Quantum BioPharma shares surged over 80% after its licensee, Celly Nutrition, engaged a New York investment bank to raise $10 million and explore a potential U.S. initial public offering.

Benzinga

Page data last updated 08/19/2025 16:51:56 UTC